These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15066252)

  • 1. [Analysis of costs and results of the economic assessment of health interventions].
    Prieto L; Sacristán JA; Pinto JL; Badia X; Antoñanzas F; del Llano J;
    Med Clin (Barc); 2004 Mar; 122(11):423-9. PubMed ID: 15066252
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical-economic trial: promise, problems, and challenges.
    Powe NR; Griffiths RI
    Control Clin Trials; 1995 Dec; 16(6):377-94. PubMed ID: 8720016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of epilepsy treatment: a review of the literature.
    Heaney DC; Begley CE
    Epilepsia; 2002; 43 Suppl 4():10-6. PubMed ID: 12059996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic issues in defining stable funding levels for HIV/AIDS research.
    Eastaugh SR
    J Health Adm Educ; 1992; 10(1):139-49. PubMed ID: 10118035
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic analysis alongside clinical trials: practical considerations. The Economics Workgroup.
    Drummond M; O'Brien B
    J Rheumatol; 1995 Jul; 22(7):1418-9. PubMed ID: 7562789
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic analysis of epilepsy care.
    Beran RG
    Epilepsia; 1999; 40 Suppl 8():19-24. PubMed ID: 10563591
    [No Abstract]   [Full Text] [Related]  

  • 7. A method for predicting accrual, cost, and paper flow in clinical trials.
    Piantadosi S; Patterson B
    Control Clin Trials; 1987 Sep; 8(3):202-15. PubMed ID: 3665522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting cost analyses of clinical interventions.
    Balas EA; Kretschmer RA; Gnann W; West DA; Boren SA; Centor RM; Nerlich M; Gupta M; West TD; Soderstrom NS
    JAMA; 1998 Jan; 279(1):54-7. PubMed ID: 9424045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost as a study outcome: sensitivity of study conclusions to the method of estimating cost.
    Chapko MK; Hedrick S
    Med Care; 1999 Apr; 37(4 Suppl Va):AS37-44. PubMed ID: 10217383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials: rising costs limit innovation.
    Johnston SC; Hauser SL
    Ann Neurol; 2007 Dec; 62(6):A6-7. PubMed ID: 18161783
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 12. Registering clinical trials is necessary for ethical, scientific and economic reasons.
    Antes G
    Z Arztl Fortbild Qualitatssich; 2004 Aug; 98(5):422. PubMed ID: 15487390
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the costs of healthcare technologies in clinical trials.
    Johnston K; Buxton MJ; Jones DR; Fitzpatrick R
    Health Technol Assess; 1999; 3(6):1-76. PubMed ID: 10350450
    [No Abstract]   [Full Text] [Related]  

  • 14. On estimating costs for economic evaluation in failure time studies.
    Hallstrom AP; Sullivan SD
    Med Care; 1998 Mar; 36(3):433-6. PubMed ID: 9520967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan.
    Shen LJ; Chou H; Huang CF; Chou GM; Chan WK; Wu FL
    Contemp Clin Trials; 2011 Jul; 32(4):485-91. PubMed ID: 21530679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of clinical trials in cancer.
    Snyder RD; Burns WI
    Aust Health Rev; 1982 May; 5(2):27-8. PubMed ID: 10256885
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials.
    Taira DA; Seto TB; Siegrist R; Cosgrove R; Berezin R; Cohen DJ
    Am Heart J; 2003 Mar; 145(3):452-8. PubMed ID: 12660668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The overall benefits risks and costs of multiple medical interventions may be less favourable than the sum of the benefits risks and costs of those individual interventions.
    Fitzgerald SP
    Med Hypotheses; 2007; 69(5):970-3. PubMed ID: 17555886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Researching the cost of research.
    Wright JR; Levine MN
    J Clin Oncol; 2003 Nov; 21(22):4081-2. PubMed ID: 14559890
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of paper-based and electronic data collection process in clinical trials: Costs simulation study.
    Lu Z
    Contemp Clin Trials; 2010 Jan; 31(1):4. PubMed ID: 19895905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.